Company / PP&E (Net)
iBio, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$3.2M
FY2025
5-year range
$3.2M / $36.7M
FY2021-FY2025
Trend
-25.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 10 years, ranging from $3M in FY2025 to $37M in FY2022.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -2.9%.
Declined from $4M to $3M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -55.8%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.9%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 25.0% year-over-year.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.2M | -25.0% |
| FY2024 | $4.2M | +0.0% |
| FY2023 | $4.2M | -88.5% |
| FY2022 | $36.7M | +324.9% |
| FY2021 | $8.6M | +135.9% |
| FY2020 | $3.7M | -85.0% |
| FY2019 | $24.4M | -3.1% |
| FY2018 | $25.2M | -1.7% |
| FY2017 | $25.6M | +0.1% |
| FY2016 | $25.6M | +196623.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026